RPRX - Teva hits a five-year high on schizophrenia trial win Q1 beat
2024-05-08 10:13:13 ET
More on Teva Pharmaceutical
- Teva Pharmaceutical Industries Limited 2024 Q1 - Results - Earnings Call Presentation
- Teva Pharmaceutical Industries: Potential Outweighs Concerns
- Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities
- Teva, Medincell succeed in late-stage trial for injectable schizophrenia therapy
- Teva Pharmaceutical reports mixed Q1 results; reaffirms FY24 outlook